Concepedia

Author

Gunhild Keller

Tulane University

Also Known As

G H KELLER, G H Keller, G H M Keller, G. H. M. Keller, G.H.M. KELLER, G.H.M. Keller, Gunhild Keller, Gunhild Keller (104356)

53

Publications

2.2K

Citations

23

H-Index

47

Concepts

All Affiliations

Tulane UniversityUniversity Medical Center Hamburg-EppendorfVeterans Health AdministrationUniversität HamburgCancer Institute (WIA)
GK

About

Gunhild Keller is an author at Tulane University specializing in medicine, pharmacology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

10

337

2

Endocrinology

3

3

84

3

Health Sciences

2

2

27

4

Public Health

2

2

48

5

Cell Biology

2

2

62

Gunhild Keller

×

26

Publications

2K

Citations

20

H-Index

YearCitations

Nephron Number in Patients with Primary Hypertension

Gunhild Keller, Gisela Zimmer, Gerhard Mall,

New England Journal of Medicine

2003

1.1K

Simultaneous targeting of Aurora kinases and Bcr-Abl kinase by the small molecule inhibitor PHA-739358 is effective against imatinib-resistant BCR-ABL mutations including T315I

Artur Gontarewicz, Stefan Balabanov, Gunhild Keller,

Blood

2008

165

Impact of the CCR5 gene polymorphism on the survival of metastatic melanoma patients receiving immunotherapy

Selma Ugurel, David Schrama, Gunhild Keller,

Cancer Immunology Immunotherapy

2007

88

Aurora Kinase Inhibitor PHA-739358 Suppresses Growth of Hepatocellular Carcinoma In Vitro and in a Xenograft Mouse Model

Daniel Benten, Gunhild Keller, Alexander Quaas,

Neoplasia

2009

67

Multi tyrosine kinase inhibitor dasatinib as novel cause of severe pre-capillary pulmonary hypertension?

Jan K. Hennigs, Gunhild Keller, Hans Jörg Baumann,

BMC Pulmonary Medicine

2011

59

Abcg2 Overexpression Represents a Novel Mechanism for Acquired Resistance to the Multi-Kinase Inhibitor Danusertib in BCR-ABL-Positive Cells In Vitro

Stefan Balabanov, Artur Gontarewicz, Gunhild Keller,

PLoS ONE

2011

44

Human Malignant Melanomas Express Receptors for Luteinizing Hormone Releasing Hormone Allowing Targeted Therapy with Cytotoxic Luteinizing Hormone Releasing Hormone Analogue

Gunhild Keller, Andrew V. Schally, Timo Gaiser,

Cancer Research

2005

41

Therapy of ovarian cancers with targeted cytotoxic analogs of bombesin, somatostatin, and luteinizing hormone-releasing hormone and their combinations

Stefan Buchholz, Gunhild Keller, Andrew V. Schally,

Proceedings of the National Academy of Sciences

2006

37

Targeting Aurora Kinases with Danusertib (PHA-739358) Inhibits Growth of Liver Metastases from Gastroenteropancreatic Neuroendocrine Tumors in an Orthotopic Xenograft Model

Katharina Fraedrich, Jörg Schrader, Harald Ittrich,

Clinical Cancer Research

2012

37

Inhibition of Growth of Experimental Human Endometrial Cancer by an Antagonist of Growth Hormone-Releasing Hormone

J. Engel, Gunhild Keller, Andrew V. Schally,

The Journal of Clinical Endocrinology & Metabolism

2005

36

Page 1